Latest Share Chat

REMOVE ADS

Diaceutics Share News (DXRX)

Diaceutics Information

Share Price Information for Diaceutics (DXRX)

Share Price is delayed by 15 minutes

Get Live Data

142.50 0.00 (0.00%)

Bid:

142.00

Ask:

143.00

Spread: 1.00 (0.704%)

Market Cap: £120.60m

Last checked at -

Intraday Diaceutics Share Chart

REMOVE ADS

Diaceutics News

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Alternative Income assets rise; Ironveld signs deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

EARNINGS SUMMARY: Animalcare profit climbs; Silver Bullet revenue up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

IN BRIEF: Diaceutics in positive start to 2022 as order book grows

Diaceutics PLC - Belfast-based testing laboratories company - Posts revenue of GBP7.5 million for the six months that ended on June 30, up 25% from GB...

Diaceutics wins USD2 million contract with "top five global" drug firm

(Alliance News) - Diaceutics PLC on Monday it will deliver customised data insights to a "top five global" pharmaceutical firm under a new contract.

Diaceutics secures $2m multi-year contract with global pharma company

(Sharecast News) - Diagnostic commercialisation company Diaceutics has secured a multi-year contract win with an unnamed "top five" global pharmaceuti...

IN BRIEF: Diaceutics enhances platform to improve customer experience

Diaceutics PLC - UK testing laboratories company - Announces "significant enhancements" to its DXRX platform in order to improve user experience. Comp...

IN BRIEF: Diaceutics wins five-year contract worth over USD1 million

Diaceutics PLC - UK testing laboratories company - Wins five-year contract worth at least USD1 million with an unnamed "top 30 global" pharmaceutical ...